In this study, an in vivo and in vitro model of cerebral ischemia was used to answer whether the neuroprotective effects of the traditional Chinese medicine Rg1 could be attributed to PPARγ-mediated regulation of cerebral inflammation and oxidative stress. The gene discussed is PPARG; the disease is brain ischemia.